ArticleProtein science : a publication of the Protein Society2025
Mitigating product inhibition in 2'-hydroxybiphenyl-2-sulfinate desulfinase (DszB) with synthetic glycosylation.
Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitigating product inhibition in 2'-hydroxybiphenyl-2-sulfinate desulfinase (DszB) with synthetic glycosylation.Protein science : a publication of the Protein Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The combustion of sulfur-rich crude oil is toxic to the environment, making the removal of sulfur impurities a priority for the sustainable use of liquid fuels. Biodesulfurization via the 4S pathway is a promising approach due to its C-S bond cleavage specificity and mild operating conditions. However, biodesulfurization is not economically viable due to the slow turnover of 2'-hydroxybiphenyl-2-sulfinate desulfinase (DszB), an enzyme catalyzing the conversion of 2'-hydroxybiphenyl-2-sulfinate to 2-hydroxybiphenyl and sulfite. Previous studies have identified product inhibition as the limiting factor in DszB, whereby solvent-exposed protein loops obstruct the active site after substrate binding. This closed conformation is stabilized by hydrophobic interactions between the loops and the product. Here, we propose an artificial glycosylation strategy to mitigate product inhibition in DszB. We modeled glycated DszB in the apo, ligand-bound, and product-bound states with molecular dynamics based on the AMOEBA polarizable force field, and analyzed the chemical positioning of the reactant and product compared to the wild type (WT). We find that the addition of glucose on three Ser loop residues increases the interaction of the loops with water, overcoming the weaker product-loop interactions, and thereby enabling product release. Importantly, the enhanced flexibility of the loops was subtle enough to not heavily disrupt the chemical positioning of the reactant, which suggests that the rate acceleration would be similar to that of the WT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.